Loading...
Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
Coronavirus disease 2019 (COVID-19) is first detected in December 2019 in Wuhan, China which is a new pandemic caused by SARS-COV-2 that has greatly affected the whole world. Bruton tyrosine kinase (BTK) inhibitors are drugs that are used for the management of cancer, and are being repurposed for CO...
Na minha lista:
| Udgivet i: | Metabol Open |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318668/ https://ncbi.nlm.nih.gov/pubmed/34345815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metop.2021.100116 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|